Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 51: 603-609, 2005. First published January 6, 2005; 10.1373/clinchem.2004.041350
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow A correction has been published
Right arrow All Versions of this Article:
clinchem.2004.041350v1
51/3/603    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (17)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fernández-Real, J.-M.
Right arrow Articles by Ricart, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fernández-Real, J.-M.
Right arrow Articles by Ricart, W.
Related Collections
Right arrow Lipids, Lipoproteins, and Cardiovascular Risk Factors
Right arrow Endocrinology and Metabolism
(Clinical Chemistry. 2005;51:603-609.)
© 2005 American Association for Clinical Chemistry, Inc.


Endocrinology and Metabolism

Circulating Adiponectin and Plasma Fatty Acid Profile

José-Manuel Fernández-Real1,a, Joan Vendrell2 and Wifredo Ricart1

1 Section of Diabetes, Endocrinology and Nutrition, University Hospital of Girona "Dr Josep Trueta", Girona, Spain.
2 Section of Diabetes, Endocrinology and Nutrition, University Hospital of Tarragona, Tarragona, Spain.

aAddress correspondence to this author at: Unitat d’Endocrinologia, Diabetes i Nutrició, Hospital de Girona, Carretera de Francia s/n, 17007 Girona, Spain. Fax 34-972-940270; e-mail uden.jmfernandezreal{at}htrueta.scs.es.

Background: The amount and type of fat in the diet influence the development of obesity and related inflammatory activity. Knowledge of the possible influence of dietary habits on circulating adiponectin, a molecule with putative antiinflammatory properties, may be helpful in preventing atherosclerosis and type 2 diabetes.

Methods: The association between dietary fat, as inferred from plasma fatty acid composition (gas–liquid chromatography), and circulating adiponectin (RIA) was evaluated in 116 healthy individuals.

Results: The proportion of saturated fatty acids in plasma was significantly associated with circulating adiponectin concentration (r = –0.24; P = 0.01). Specifically, percentage of palmitic acid (C16:0) was significantly associated with lower adiponectin concentration (r = –0.28; P = 0.002), particularly among women (r = –0.37; P = 0.02) and nonsmokers (r = –0.30; P = 0.007). Percentage of myristic acid (C14:0) was also significantly associated with lower adiponectin among nonsmokers (r = –0.26; P = 0.02) and women (r = –0.39; P = 0.01). The other fatty acids were not significantly associated with adiponectin except for eicosanoic acid (C20:1 {omega}-9), which was significantly and positively associated with adiponectin in all individuals (r = 0.23; P = 0.01). This latter association was most significant in smokers (r = 0.43; P = 0.007). In a multivariate regression analysis to predict circulating adiponectin, after controlling for age, body mass index, waist-to-hip ratio, and the individual remaining fatty acids, the percentages of palmitic (P = 0.005) and eicosanoic acid (P = 0.03) contributed independently (6% and 3%, respectively) to adiponectin variance. Among nonsmokers, the percentages of palmitic acid (P = 0.01) and {omega}-3 fatty acids contributed 8% and 7%, respectively, to adiponectin variance. Among smokers, the percentage of eicosanoic acid (P = 0.03) contributed to 10% of adiponectin variance, independently of body mass index, age, waist-to hip ratio, and the remaining individual fatty acids.

Conclusions: Saturated and {omega}-3 fatty acids of dietary origin (as inferred from plasma fatty acid concentration) are associated with circulating adiponectin concentrations in healthy humans. The proportion of eicosanoic acid also appears to be positively associated with circulating adiponectin. The knowledge of how these interactions occur may be helpful in the planning of dietary measures aimed at the modulation of inflammatory activity.




The following articles in journals at HighWire Press have cited this article:


Home page
Exp Biol MedHome page
R. R. Kraemer and V. D. Castracane
Exercise and Humoral Mediators of Peripheral Energy Balance: Ghrelin and Adiponectin
Exp Biol Med, February 1, 2007; 232(2): 184 - 194.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
C. S Mantzoros, C. J Williams, J. E Manson, J. B Meigs, and F. B Hu
Adherence to the Mediterranean dietary pattern is positively associated with plasma adiponectin concentrations in diabetic women.
Am. J. Clinical Nutrition, August 1, 2006; 84(2): 328 - 335.
[Abstract] [Full Text] [PDF]

eLetters:

Read all eLetters

Correction
José-Manuel Fernández-Real, et al.
Clinical Chemistry Online, 21 Jun 2005 [Full text]



HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the American Association for Clinical Chemistry.